Cargando…
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great attention for its therapeutic potential against different pathologies including skin diseases. However, although the efficacy in preclinical models and the clinical benefits of CBD in humans have been extensively d...
Autores principales: | Casares, Laura, García, Víctor, Garrido-Rodríguez, Martín, Millán, Estrella, Collado, Juan A., García-Martín, Adela, Peñarando, Jon, Calzado, Marco A., de la Vega, Laureano, Muñoz, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742916/ https://www.ncbi.nlm.nih.gov/pubmed/31518892 http://dx.doi.org/10.1016/j.redox.2019.101321 |
Ejemplares similares
-
Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity
por: Casares, Laura, et al.
Publicado: (2020) -
Cannabidiol and Other Cannabinoids in Demyelinating Diseases
por: Navarrete, Carmen, et al.
Publicado: (2021) -
Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
por: Carmona-Hidalgo, Beatriz, et al.
Publicado: (2021) -
A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury
por: Navarrete, Carmen, et al.
Publicado: (2022) -
Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2
por: Morrugares, Rosario, et al.
Publicado: (2019)